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Background: Herbal medicine has long been viewed as a valuable asset for potential new drug discovery and
herbal ingredients’ metabolites, especially the in vivo metabolites were often found to gain better pharmacological,
pharmacokinetic and even better safety profiles compared to their parent compounds. However, these herbal
metabolite information is still scattered and waiting to be collected.
Description: HIM database manually collected so far the most comprehensive available in-vivo metabolism
information for herbal active ingredients, as well as their corresponding bioactivity, organs and/or tissues
distribution, toxicity, ADME and the clinical research profile. Currently HIM contains 361 ingredients and 1104
corresponding in-vivo metabolites from 673 reputable herbs. Tools of structural similarity, substructure search and
Lipinski’s Rule of Five are also provided. Various links were made to PubChem, PubMed, TCM-ID (Traditional Chinese
Medicine Information database) and HIT (Herbal ingredients’ targets databases).
Conclusions: A curated database HIM is set up for the in vivo metabolites information of the active ingredients for
Chinese herbs, together with their corresponding bioactivity, toxicity and ADME profile. HIM is freely accessible to
academic researchers at http://www.bioinformatics.org.cn/.
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As one of the naturally originated medical systems, Chinese
herbal medicine (CHM) has developed for several thou-
sand years and accumulated plenty of clinical experiences
and pharmacological information to form its own inte-
grated theory system [1]. Being a multi-component and
multi-target therapy methodology, the studies on its mo-
lecular mechanism have made a great progress in recent
years although much more still remains unclear [2-4]. In
order to get a deeper insight into the mechanism of CHM,
various modern scientific technologies have been applied
to separate and purify the active ingredients from herbs
and elucidate their pharmacodynamic characteristics [5].
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reproduction in any medium, provided the ortested [6-8]. More interestingly, during many researches
[9-11], active metabolites were sometimes found to gain
better pharmacological, pharmacokinetic and safety pro-
files compared to their respective parent compounds. For
example, morphine is a widely used analgesic which was
extracted from Papaver somniferum L and its major thera-
peutic benefit is mediated by morphine-6-glucuronide, an
active metabolite of morphine [12,13]. Another example,
Ginsenoside-Rb1, a major active ingredient of Panax gin-
seng, is found to have the antiallergic activity through its
main metabolite named compound K instead of itself [14].
Similarly, glycyrrhizic acid, an alicyclic compound which
was extracted from Glycyrrhiz glabra L, has no effect of
anti-lipid peroxidation in rat hepatocyte, while its metab-
olite, glycyrrhetinic acid, has the inhibitory effect on lipid
peroxidatioin in dose-dependent manner [15]. Many other
similar instances can be found which implies an important
message that metabolites of herbal ingredients could be
highly valuable for new drug discovery.
Currently, abundant metabolism information of herbal
active ingredients has been produced with the progressl Ltd. This is an Open Access article distributed under the terms of the Creative
commons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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several databases such as MDL Metabolite Database [16]
and Accelrys Metabolism Database [17] for synthetic
compounds whose pharmacokinetic and metabolism
data have been carefully stored, there is still lack of
specific database to collect and store the correspond-
ing information for herbal active ingredients. It is
noted that synthetic compounds metabolic databases
have made great contributions to new drug discovery
[18]. Constructing a database collected the CHM in-
gredients metabolism information could also have sub-
stantial positive impact on TCM development.
In our previous work, in order to collect available re-
sources of protein targets for FDA-approved drugs and
the promising precursors, we developed HIT [19]
(http://lifecenter.sgst.cn/hit/). Served as a serial work
after HIT, HIM is a database which aims to provide the
systematical and accurate data storage, data access as
well as data analysis (i.e., structural similarity search and
substructure analysis) for the herbal active ingredients
in vivo metabolism information. In this work, the in vivo
metabolism data of those active ingredients extracted
from herbs were collected from literature, unpublished
in-house experimental data and the Chinese herbal med-
ical monographs. The information from all these hetero-
geneous data sources was further processed and
integrated into a well-designed database. The informa-
tion of each ingredient was divided into three categories:
identification label, metabolic scheme and bioactivity in-
formation. Additionally, properties like the number of
hydrogen bond (H-bond) donors and acceptors, molecu-
lar weight or the octanol-water partition coefficient logP,
which allow the evaluation of the Lipinski’s Rule of Five,
can be found within the database. The 2D structures of
all the compounds are available and the structure simi-
larity search function and substructure search function
are also provided. In summary, up to now, there are 361
active ingredients from 673 Chinese herbs and 1104 cor-
responding metabolites stored in HIM. All the data were




The data in HIM were compiled from both primary and
secondary sources.
First, Chinese herbal ingredients in vivo metabolism
data were extracted from PubMed [20] literature by
searching with key words: metabolism, metabolite, bio-
transformation, metabolic, CHM, Chinese herbal medi-
cine, in vivo. Then a preliminary screening was carried
out by browsing all the abstracts manually. After that we
checked the full text for all the qualified articles and
extracted the information according the databasecriterion. At last, the data is confirmed when they passed
the quality control process which consists of rechecking
and revising. In summary, about one-third of all entries
come from literatures.
Second, metabolism data were extracted from the
book entitled “Absorption, Distribution, Metabolism,
Excretion, Toxicity and Activity of The Chemical Con-
stituents in Traditional Chinese Medicines” [21]. This
book is a well-known TCM monograph which is
concerning ADME/T (Absorption, Distribution, Me-
tabolism, Excretion and Toxicity) of CHM active ingre-
dients in China. Approximately half of the entries in
the database are derived from this book, which made
such valuable information available online for the first
time.
Third, some unpublished in vivo experimental data
about CHM ingredients metabolism are also gathered in
HIM, which accounts for the remaining minority of the
entries.
Content and details
The database HIM comprises three data fields for each
active ingredient: identification label, metabolic scheme
and bioactivity information.
Identification label
In this field, following information is provided for each
record:
Common, Alias and Systematic Names. Both the Chinese
pinyin and the common English name are provided. The
aliases of each active ingredient that are obtained from the
database SciFinder [22] are also listed. The systematic name
presents precise details of a chemical structure which is
generated based on the IUPAC names of natural product
skeletal types.
CAS Registry Number. CAS number provides a reli-
able link between different systems of nomenclature as
well as an access to future information on every ingredi-
ent. In addition, the compounds are also annotated with
the CID numbers provided by PubChem [23] with a
hyperlink to it.
Botanical Species. Latin binomials of the herbs and the
corresponding region of the plant in which the ingredi-
ent located are listed.
Metabolic scheme
In this field, detailed information about in vivo me-
tabolism data of each CHM active ingredient is
available.
Molecular Weight and Molecular Formula. The MW
and MF of all compounds are given by using the func-
tions provided by Marvin Bean [24], a JAVA package
supplied by ChemAxon [25].
Figure 1 Primary pages in HIM. (A) Keywords Text Search (B) Draw a molecular structure for structure search (C) Upload a MOL/SDF file
for structure search (D) Result page of ‘Text Search’ with ‘Name: Shikonin’. (E) Result page of ‘Structure Similarity Search’ with the structure
of the compound: Shikonin. (F) Detail Information of the compound: Shikonin (G) Lipinski’s Rule of Five properties for one metabolite
of Shikonin.
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tabolites, a 2D structure which is stored in MDL mol for-
mat in HIM is shown in JPEG format on the web page.Metabolite and Metabolic Scheme. All the metabolites
of each active ingredient and the full view of in vivo
metabolic process are provided in HIM.
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In this field, extensive information about the pharmaco-
kinetic (ADME) properties, bioactivity and toxicity of
each active ingredient are listed.
Bioactivity
Some general concepts like anti-cancer, anti-inflammation,
anti-bacteria, etc. rather than the diseases-related protein
targets are used to describe the bioactivity of each active
ingredient.
Toxicity
As being generally recognized, LD50 (median lethal
dose) value is used to represent the toxicity with some
concrete descriptions for each ingredient.
Other Information. Besides the bioactivity and toxicity,
some other information such as absorption, distribution,
clinical research and the main references are also avail-
able (see Figure 1).
Additional functions
Text search
The “Text Search” function in the homepage of the web-
site provides five distinctive items to search the whole
database: Compound name, CAS Number, CID Number,
Molecular Formula and Keywords.
Structure similarity search
The “Structure Similarity Search” can be done by
uploading a compound structure in MOL/SDF format or
via drawing the structure as you want with an embeddedFigure 2 Lipinski’s rule of five properties statistics. (A) Molecular Weigh
(D) H-bond Acceptors.molecule editor applet, Marvin Sketch [24]. The struc-
ture similarity search is performed by using the so-called
structural fingerprint, a binary string with a length of
1024 bits which has encoded the structure characteris-
tics of a given compound. Note that the fingerprint is
generated by the Chemistry Development Kit (CDK)
[26]. Then the Tanimoto coefficient is calculated by the
background program. A molecule with a Tanimoto coef-
ficient ≥ 0.85 to an active compound is often assumed to
own similar biological activity [27].
Substructure search
Chemical substructure-based in silico techniques have
been wildly used as an effective and popular approach to
reduce the cost in identifying molecules suitable for
pharmaceutical development in early stage of drug dis-
covery [28,29]. In our database HIM, substructure search
is also available by JChem [30].
Website and server
HIM is available online at: http://www.bioinformatics.
org.cn/. It is designed as a relational database and
implemented in MySQL Server 5.0 with the Apache
Tomcat 6.0 as the web server. For chemical calculation
and structure drawing, CDK package and Marvin Sketch
applet are embedded. The website is built in JSP, HTML
and CSS.
Utility
HIM (http://www.bioinformatics.org.cn/), which is pro-
posed in this work, is served as a serial work after HITt (B) Octanol-water Partition Coefficient logP (C) H-bond Donors
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explicit in vivo metabolism data, since the active metab-
olites of CHM were sometimes found to gain better
pharmacological, pharmacokinetic and safety profiles
compared to their respective parent compounds. With
the help of HIM, researches could find out the mechan-
ism of pharmacological action of CHM more compre-
hensively, which is expected to have a substantial
positive impact on CHM development.Discussion
Although having been used for thousands of years and
own outstanding reputation, the mechanism of CHM is
still largely unknown. One reason contributing to this is
that it is unclear for the process of ADME/T in vivo
such as in vivo metabolism of CHM. HIM is constructed
as the first database to store almost all the CHM active
ingredients in vivo metabolism data dated to January of
2012, as well as their corresponding bioactivity, toxicity,
and ADME profile. The properties of Lipinski’s rule of
five for each compound are also given to the whole data-
base. As one of the common rules, Lipinski’s rule of five
is widely used in drug screening and design. Blake’s [31]
study has shown that for the five stages from pre-clinical
to approved, less and less compounds break the
Lipinski’s rules. It is indicated that compounds which
are against the Lipinski’s rule need to be modified too
much and they are little probability to be a drug. In
HIM about 90% of the compounds (herbal ingredients
and their metabolites) meet the Lipinski’s rule (Figure 2).
We hope that HIM can be served as a valuable database
to make the progress of CHM modernization and pro-
vide great assistance in the new drug discovery and
developments.Conclusion
HIM can be used to get the metabolites of the active in-
gredient which the researchers are interested in. The
structure similarity search and substructure search can
be applied to get compounds which potentially similar
bioactivity to the query compound and can provide
other chemical and biologic information of the query
molecule. Moreover, the database is useful for the study
of pharmacognosy. Although some active metabolic
intermediates are unstable and hard to get, fermenta-
tion technology such as microbial transformation
could be used to obtain the active compounds which
are the in vivo metabolites of CHM. Crude herbal
medicines could be fermented by certain microbial
strains and get certain products [32,33]. HIM could
provide valuable information for the researchers who
are interested in TCM, drug design, pharmacognosy,
drug metabolism, etc.Competing interests
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